Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Roche, Adaptive Biotech, GenTegra, More

Roche Cobas HPV Self Sampling Solution

Roche has launched a human papillomavirus self-collection solution in countries accepting the CE mark. The new sample type falls under the Cobas HPV test's original CE marking in 2017, Roche said. The solution allows patients to collect their own vaginal samples in a healthcare facility following instructions from a healthcare worker and is intended to provide an alternative to more invasive clinician collection procedures.

The Cobas HPV test is indicated for use for routine cervical cancer screening, including HPV primary screening, co-testing with cytology, and for triage of women with abnormal cytology. The test runs on the fully automated Cobas 6800/8800 instrument.

Adaptive Biotechnologies T-Detect Lyme

Adaptive Biotechnologies has launched T-Detect Lyme, the second product in the company’s growing T-Detect immune testing franchise. Administered as a blood test, T-Detect Lyme identifies T cells activated by Borrelia burgdorferi, the bacterium that causes Lyme disease, to help diagnose early disease, the company said. The test is designed for adult patients demonstrating signs and symptoms including but not limited to the presence of an erythema migrans rash, fever, chills, headache, fatigue, muscle and joint aches, and swollen lymph nodes, according to the company. Adaptive said T-Detect Lyme is available to patients with a prescription through a qualified healthcare professional as a CLIA laboratory-developed test service.

GenTegra RNAdvantage

GenTegra has launched RNAdvantage, its latest RNA stabilization product for fresh tissue samples. As with GenTegra's other RNA stabilization products — RNAssure for purified liquid RNA and GenTegraRNA for ambient shipping and long-term storage — RNAdvantage was developed with the company's patented "active chemical protection" technology. GenTegra's nucleic acid stabilization technology is designed to protect and preserve DNA and RNA in research applications, whole blood sample collection cards, emerging devices for remote patient sample collection, and in support of initiatives to reduce the reliance on lab freezers for long-term storage of valuable nucleic acid samples.

For more new products and services, please visit the New Products page on our website.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.